Naltrexone for reducing self-injury
Treatments studied
Part of Mental health clinical trials.
This study tests whether a medication called naltrexone can help reduce the urge or behavior of self-injury (hurting yourself on purpose) in people who have not improved with standard treatment. It may offer a new option to manage these urges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older
- You have been diagnosed with nonsuicidal self-injury (hurting yourself without intending to end your life)
- You have self-injured more than once in the past two months
- You feel a strong desire or urge to self-injure (score of 2 or more on a craving scale)
- Self-injury continues even after at least 4 weeks of standard psychiatric treatment
- You can read and speak Korean and give written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the medication naltrexone can help reduce self-harm urges or actions in people who hurt themselves without intending suicide. It may offer a new option if current treatments haven't been enough.
This Phase 4 study tests whether naltrexone injections can help people with alcohol use disorder (AUD) reduce or stop heavy drinking. You may get two injections over 8 weeks, and you can join if you meet specific drinking pattern and eligibility rules.
This study tests a long-acting implant that releases naltrexone slowly over time to help prevent relapse in people with opioid use disorder. The implant is placed under the skin in a minor procedure and may help you stay opioid-free.
This study tests a small implant that slowly releases naltrexone, a medicine that helps reduce alcohol cravings. It may help people with alcohol use disorder stay sober, and the implant offers a long-acting option that doesn't require daily pills.
This Phase 2 study tests whether low-dose naltrexone can reduce pain from vulvodynia. It also looks at how well it works across different vulvodynia types, comparing to what participants are already doing for symptoms.
This study tests a new implant (BICX104) with or without bupropion to see how safe it is and how it works in the body, compared to an existing treatment (Vivitrol). If you are healthy and not using opioids, you may be eligible to help researchers understand if this implant could be a new option for treatment.
Hear when a new Nonsuicidal Self Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.